Teleflex Revenue 2010-2024 | TFX
Teleflex annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Teleflex revenue for the quarter ending September 30, 2024 was $0.764B, a 2.41% increase year-over-year.
- Teleflex revenue for the twelve months ending September 30, 2024 was $3.026B, a 2.27% increase year-over-year.
- Teleflex annual revenue for 2023 was $2.974B, a 6.57% increase from 2022.
- Teleflex annual revenue for 2022 was $2.791B, a 0.66% decline from 2021.
- Teleflex annual revenue for 2021 was $2.81B, a 10.74% increase from 2020.
| Teleflex Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $2,974 |
| 2022 | $2,791 |
| 2021 | $2,810 |
| 2020 | $2,537 |
| 2019 | $2,595 |
| 2018 | $2,448 |
| 2017 | $2,146 |
| 2016 | $1,868 |
| 2015 | $1,810 |
| 2014 | $1,840 |
| 2013 | $1,696 |
| 2012 | $1,551 |
| 2011 | $1,493 |
| 2010 | $1,398 |
| 2009 | $1,435 |
| Teleflex Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $764 |
| 2024-06-30 | $750 |
| 2024-03-31 | $738 |
| 2023-12-31 | $774 |
| 2023-09-30 | $746 |
| 2023-06-30 | $743 |
| 2023-03-31 | $711 |
| 2022-12-31 | $758 |
| 2022-09-30 | $687 |
| 2022-06-30 | $705 |
| 2022-03-31 | $642 |
| 2021-12-31 | $762 |
| 2021-09-30 | $700 |
| 2021-06-30 | $713 |
| 2021-03-31 | $634 |
| 2020-12-31 | $711 |
| 2020-09-30 | $628 |
| 2020-06-30 | $567 |
| 2020-03-31 | $631 |
| 2019-12-31 | $681 |
| 2019-09-30 | $648 |
| 2019-06-30 | $653 |
| 2019-03-31 | $614 |
| 2018-12-31 | $642 |
| 2018-09-30 | $610 |
| 2018-06-30 | $610 |
| 2018-03-31 | $587 |
| 2017-12-31 | $595 |
| 2017-09-30 | $535 |
| 2017-06-30 | $529 |
| 2017-03-31 | $488 |
| 2016-12-31 | $514 |
| 2016-09-30 | $456 |
| 2016-06-30 | $474 |
| 2016-03-31 | $425 |
| 2015-12-31 | $485 |
| 2015-09-30 | $444 |
| 2015-06-30 | $452 |
| 2015-03-31 | $429 |
| 2014-12-31 | $476 |
| 2014-09-30 | $457 |
| 2014-06-30 | $468 |
| 2014-03-31 | $439 |
| 2013-12-31 | $451 |
| 2013-09-30 | $414 |
| 2013-06-30 | $420 |
| 2013-03-31 | $412 |
| 2012-12-31 | $419 |
| 2012-09-30 | $368 |
| 2012-06-30 | $383 |
| 2012-03-31 | $381 |
| 2011-12-31 | $395 |
| 2011-09-30 | $363 |
| 2011-06-30 | $381 |
| 2011-03-31 | $354 |
| 2010-12-31 | $327 |
| 2010-09-30 | $345 |
| 2010-06-30 | $358 |
| 2010-03-31 | $367 |
| 2009-12-31 | $115 |
| 2009-09-30 | $441 |
| 2009-06-30 | $439 |
| 2009-03-31 | $440 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.419B | $2.974B |
| Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.066B | 26.11 |
| Intuitive Surgical (ISRG) | United States | $211.086B | 110.36 |
| Alcon (ALC) | Switzerland | $41.615B | 27.84 |
| Edwards Lifesciences (EW) | United States | $41.156B | 26.14 |
| IQVIA Holdings (IQV) | United States | $35.821B | 19.74 |
| IDEXX Laboratories (IDXX) | United States | $34.331B | 40.43 |
| DexCom (DXCM) | United States | $32.958B | 49.63 |
| Waters (WAT) | United States | $23.988B | 35.47 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.710B | 0.00 |
| Hologic (HOLX) | United States | $15.740B | 17.09 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.538B | 13.90 |
| Globus Medical (GMED) | United States | $12.364B | 31.31 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 0.00 |
| Penumbra (PEN) | United States | $10.120B | 99.13 |
| Masimo (MASI) | United States | $9.225B | 44.63 |
| Glaukos (GKOS) | United States | $8.623B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
| Inari Medical (NARI) | United States | $4.657B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.967B | 0.00 |
| Veracyte (VCYT) | United States | $3.145B | 94.37 |
| Nihon Kohden (NHNKY) | Japan | $2.658B | 20.19 |
| LivaNova (LIVN) | United Kingdom | $2.623B | 15.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.309B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 19.48 |
| TransMedics (TMDX) | United States | $1.920B | 60.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| Alphatec Holdings (ATEC) | United States | $1.641B | 0.00 |
| Artivion (AORT) | United States | $1.288B | 85.33 |
| RxSight (RXST) | United States | $1.225B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.083B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.911B | 0.00 |
| AxoGen (AXGN) | United States | $0.796B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.758B | 17.88 |
| IRadimed (IRMD) | United States | $0.750B | 40.53 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.732B | 12.44 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.693B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.658B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.599B | 31.55 |
| Treace Medical Concepts (TMCI) | United States | $0.543B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.503B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.458B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| CVRx (CVRX) | United States | $0.428B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.418B | 22.60 |
| ClearPoint Neuro (CLPT) | United States | $0.415B | 0.00 |
| NeuroPace (NPCE) | United States | $0.357B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.273B | 0.00 |
| Inogen (INGN) | United States | $0.249B | 0.00 |
| Accuray (ARAY) | United States | $0.225B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| Nevro (NVRO) | United States | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.144B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.108B | 11.51 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| 908 Devices (MASS) | United States | $0.104B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| Neuronetics (STIM) | United States | $0.075B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.071B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.93 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.008B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |